Pharmaceutical

GSK CEO addresses declining trust in vaccines following Trump re-election

GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to gauge impact.

Nov 7, 2024 - 06:00
GSK CEO addresses declining trust in vaccines following Trump re-election
GSK CEO Emma Walmsley said the sector would need to wait to see who is appointed in key roles in the Trump administration to gauge impact.
Read the original article

Tags:

Previous Article

Strong Wegovy revenue growth for Novo Nordisk but shares dip

Next Article

Tevogen Bio partners Microsoft for HPV treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Crinetics acromegaly drug succeeds in late-stage trial but would face stiff competition if approved

STAT+: Crinetics acromegaly drug succeeds in late-stage...

Sep 10, 2023

Chronic fatigue syndrome estimated to affect 3.3 million in U.S., more than previously thought: CDC

Chronic fatigue syndrome estimated to affect 3.3 millio...

Dec 9, 2023

STAT+: Gilead to acquire CymaBay for $4.3 billion, adding new treatment for liver disease

STAT+: Gilead to acquire CymaBay for $4.3 billion, addi...

Feb 13, 2024